Moreira, Gustavo Marçal Schmidt Garcia
Köllner, Sarah Mara Stella
Helmsing, Saskia
Jänsch, Lothar
Meier, Anja
Gronow, Sabine
Boedeker, Christian
Dübel, Stefan
Mendonça, Marcelo
Moreira, Ângela Nunes
Conceição, Fabricio Rochedo
Hust, Michael
Funding for this research was provided by:
Conselho Nacional de Desenvolvimento Científico e Tecnológico (204693/2014-4)
Projekt DEAL
Article History
Received: 26 March 2020
Accepted: 20 August 2020
First Online: 17 September 2020
Competing interests
: MH is a shareholder of mAb-factory GmbH, YUMAB GmbH, and Norden Vaccines GmbH. SD is a shareholder of mAb-factory GmbH, YUMAB GmbH, Norden Vaccines GmbH, and Abcalis GmbH. GMSGM has options on Norden Vaccines GmbH. None of these companies is involved in this study. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.